Meris Clinical Research, based in the greater Tampa Bay area, is dedicated to advancing medical science through Phase II–IV clinical trials. Since 2010, the team has specialized in therapeutic research across COPD, asthma, infectious diseases, cardiovascular conditions, and more. Located in Brandon, Tampa, and Wesley Chapel, they focus on participant safety, robust data collection, and adherence to FDA and Good Clinical Practice standards. With a patient-centered approach and a commitment to ethical excellence, Meris drives innovation in treatment development and health outcomes.